acute myeloid leukemia
Showing NaN - NaN of 91
Acute Myeloid Leukemia Trial in Boston (MLN9708, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- MLN9708
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jan 18, 2021
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma Trial in Boston (iThermonitor)
Completed
- Acute Lymphocytic Leukemia
- +2 more
- iThermonitor
-
Boston, MassachusettsAmanda Centi
Sep 27, 2020
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts Trial in
Completed
- Acute Myeloid Leukemia
- +2 more
- GM-K562/leukemia cell vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 15, 2020
Acute Myeloid Leukemia Trial in Boston (Regorafenib)
Active, not recruiting
- Acute Myeloid Leukemia
-
Boston, MassachusettsMassachusetts general Hospital
Sep 4, 2020
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- Panobinostat (LBH589)
- 5-Azacytidine
-
Augusta, Georgia
- +37 more
Jul 20, 2020
Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)
Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Acute Myeloid Leukemia Trial in United States (SL-401)
Completed
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Acute Myeloid Leukemia
-
Duarte, California
- +8 more
Apr 6, 2020
Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)
Acute Myeloid Leukemia Trial in Canada, Germany, United States (Entospletinib, Daunorubicin, Cytarabine)
Terminated
- Acute Myeloid Leukemia
- Entospletinib
- +4 more
-
Los Angeles, California
- +16 more
Nov 13, 2019
Acute Myeloid Leukemia Trial in Worldwide (Cytarabine or Supportive Care, Dacogen (decitabine) only)
Completed
- Acute Myeloid Leukemia
- Cytarabine or Supportive Care
- Dacogen (decitabine) only
-
Los Angeles, California
- +107 more
Aug 29, 2019
Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)
Terminated
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Prexasertib
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 10, 2019
Acute Myeloid Leukemia Trial in United States (Fludarabine, Melphalan, vadastuximab talirine)
Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in Canada, United States (procedure, drug, other)
Completed
- Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +5 more
-
Birmingham, Alabama
- +446 more
Nov 28, 2018
Acute Myeloid Leukemia Trial in Worldwide (33A, , azacitidine)
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Boston (CM-CS1 T-cell infusion)
Completed
- Acute Myeloid Leukemia
- +2 more
- CM-CS1 T-cell infusion
-
Boston, MassachusettsDana-Farber Cancer Institute
May 30, 2018
Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,
Completed
- Acute Myeloid Leukemia
- Acute Myelogenous Leukemia
- Standard dose cytarabine for induction
- +3 more
-
Birmingham, Alabama
- +12 more
May 8, 2018
Acute Myeloid Leukemia, MDS Trial in Boston, New York (RO6870810)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Boston, Massachusetts
- +1 more
Dec 7, 2017
MRD Testing Before and After Hematopoietic Cell Transplantation
Completed
- Acute Myeloid Leukemia
-
Birmingham, Alabama
- +37 more
Sep 5, 2017